MYO Myomo Inc. Projected Price to Earnings

Brandmark of Myomo Inc (MYO)

Myomo, Inc. (MYO) is protected by stringent FDA controls and exceptional patents on myoelectrics. The company's forward P/E ratio reflects market expectations, with the latest value recorded as 0.00. The integration of robotics into the lives of patients with paralysis creates an indispensable ecosystem. First-mover status and the support of insurance reimbursements strengthen the business's technological moat within the rehabilitation sector.

MYO - myomo.com Projected Price to Earnings Ratio over the range 07/04/2022 - 11/15/2026

Financial and market metric breakdowns for myomo.com (MYO)

- stock quotes and analyst forecast:
Fundamental company analysis:myomo.com
Product sample of Myomo, Inc.

Portfolio managers evaluate the operating model of Myomo, Inc. (MYO) through forward earnings per share, which determines the market's willingness to pay a premium for future income amid tight Fed policy. By analyzing the company's forward P/E, investors can discern the business's ability to monetize the growth of MyoPro installations and the expansion of Medicare insurance coverage, where the stability of this metric confirms the issuer's resilience against inflationary pressures.

Competitors of Myomo, Inc. (MYO)

Forward P/E Multiple BSX|EW: Price to Expected Earnings Ratio|ResMed Corp - Projected Price to Earnings|Market Cap to Projected Earnings Insulet (PODD)|zimmerbiomet.com - Forward P/E Multiple|Projected Price to Earnings Ratio CooperCompanies|ALGN: Forward P/E Multiple|Projected Price to Earnings Ratio Globus Medical Corp (GMED)|TMDX (TransMedics Group Inc) - Forward P/E Multiple|Price to Future Earnings Ratio ATEC (Alphatec)|Projected Price to Earnings AORT (Artivion)|ENOV (Enovis Corp) - Future Price to Earnings Multiple|Future Price to Earnings Integra LifeSciences Inc. IART|ESTA - Projected Price to Earnings|Beta Bionics, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio IRADIMED CORPORATION|EMBC: Forward P/E Multiple|Price to Future Earnings Ratio TNDM|AXGN (Axogen Surgical) - Forward P/E Multiple|SI-BONE Corp (SIBN) - Market Cap to Projected Earnings|Forward P/E Multiple OFIX|Forward P/E Multiple bioventus.com (BVS)|Forward P/E Multiple KIDS (OrthoPediatrics Corp)|Forward P/E Multiple Treace Medical Concepts Inc TMCI|SRTA - Future Price to Earnings|CARL: Future Price to Earnings|RXST (RxSight, Inc.) - Projected Price to Earnings|ClearPoint Neuro Inc. - Future Price to Earnings Multiple|STXS (Stereotaxis Corporation) - Forward P/E Multiple|Projected Price to Earnings Ratio Neuronetics Inc. STIM|Future Price to Earnings Sight Sciences Inc. (SGHT)|Orchestra BioMed, Inc. (OBIO) - Forward Price to Earnings Multiple|Anika Therapeutics Inc. - Projected Price to Earnings|Forward P/E Multiple InspireMD, Inc. NSPR|Jin Medical International Ltd. - Forward P/E Multiple|Market Cap to Projected Earnings Vivani Medical VANI|Xtant Medical (XTNT) - Future Price to Earnings|Price to Expected Earnings Ratio NMTC (NeuroOne Medical Technologies Corp.)|Future Price to Earnings modular-medical.com|Projected Price to Earnings Envoy Medical, Inc. (COCH)|Forward P/E Multiple VVOS|NVNO - Projected Price to Earnings Ratio|Future Price to Earnings sintx.com SINT|TNON: Price to Future Earnings Ratio|LFWD: Projected Price to Earnings|autonomix.com - Market Cap to Future Earnings Ratio|INVO Bioscience, Inc. (IVF) - Future Price to Earnings|BBLG (Bone Biologics Corp.) - Future Price to Earnings|Projected Price to Earnings AXNX|Biolase Inc. (BIOL) - Market Cap to Projected Earnings|Future Price to Earnings Dynatronics Corp. (DYNT)|Forward P/E Multiple Paragon 28 (FNA)|Future Price to Earnings INVO Bioscience INVO